June 2023 in “Australasian Journal of Dermatology” This study examined the current prescribing patterns of Australian dermatologists in treating androgenetic alopecia in men, highlighting the limited treatment options available despite the condition's prevalence and psychological impact.
December 2024 in “Australasian Journal of Dermatology” In this study, researchers examined the prescribing patterns of Australian dermatologists for female androgenetic alopecia, finding the use of spironolactone, systemic and topical minoxidil, and combination treatments among a sample of 54 practitioners.
This study investigated dermatology providers' attitudes and recommendation behaviors regarding the use of oral minoxidil in treating androgenetic alopecia, amid its rising utilization supported by recent clinical studies demonstrating its effectiveness. Results of these assessments are not reported in the abstract.
May 2023 in “JAMA network open” After a New York Times article talked about using low-dose oral minoxidil for hair loss, more people started getting this drug prescribed, but this trend didn't last long.
12 citations
,
April 2018 in “Physiology & Behavior” In this study, clozapine reduced suicide-related behaviors in a schizophrenia-like mouse model, but its effects on exploratory behavior were counteracted by the neurosteroid inhibitor finasteride.